CTOs on the Move

Encore Unlimited

www.encoreunlimited.com

 
Encore Unlimited is a Duluth, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

MacPractice

MacPractice is a Lincoln, NE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nashville General Hospital at Meharry

Nashville General Hospital at Meharry is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Nashville General Hospital at Meharry is based in Nashville, TN. You can find more information on Nashville General Hospital at Meharry at www.nashvilleha.org

Health Integrated

Health Integrated leads the industry with Precision Empowered Care Management, enabling health plans to precisely manage their most vulnerable members. By combining actionable big data with a proven biopsychosocial model, we address the physical, psychological and social drivers impacting member health and satisfaction. As a result, plans enhance quality, achieve compliance and strengthen their financial performance, while empowering members to achieve better outcomes.

Respitech Medical Inc

Respitech Medical Inc is a Lancaster, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Oklahoma Medical Research Foundation

Established in 1946, OMRF is an independent, nonprofit biomedical research institute with more than 450 staff and over 50 labs studying cancer, heart disease, autoimmune disorders, and diseases of aging. Breakthroughs in our labs have led to three FDA-approved drugs, including the first targeted therapy approved in the U.S. for sickle cell disease and the first approved treatment for neuromyelitis optica spectrum disorder, a rare autoimmune disease. OMRF`s critical research is helping people live longer, healthier lives, one discovery at a time. Along the way, OMRF has garnered worldwide media attention, from leading scientific publications like The New England Journal of Medicine and Science to The New York Times and The Wall Street Journal. By pushing the boundaries of biomedical science, our researchers are helping to win the war against human disease, one discovery at a time.